Comparison of clopidogrel and prasugrel as prophylaxis for In-stent protrusion evaluated by optical coherence tomography in patients with ST-segment elevation myocardial infarction

Trial Profile

Comparison of clopidogrel and prasugrel as prophylaxis for In-stent protrusion evaluated by optical coherence tomography in patients with ST-segment elevation myocardial infarction

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2016

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms INSPECT-MI
  • Most Recent Events

    • 06 Oct 2016 Efficacy and safety results (n=78) published in the Circulation Journal.
    • 05 Aug 2016 Status changed from recruiting to active, no longer recruiting.
    • 05 Jul 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top